 |
|
|
Gary DahlAcademic Appointments
Appointment
Organization
Professor - Med Center Line
Member
|
Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
Publications
- O'Brien MM, Taub JW, Chang MN, Massey GV, Stine KC, Raimondi SC, Becton D, Ravindranath Y, Dahl GV "Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421." J Clin Oncol 2008; 26: 3: 414-20 More »
- Minn AY, Fisher PG, Barnes PD, Dahl GV "In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?-Response." Pediatr Blood Cancer 2007; More »
- Oosterhuis BE, Goodwin T, Kiernan M, Hudson MM, Dahl GV "Concerns about infertility risks among pediatric oncology patients and their parents." Pediatr Blood Cancer 2007; More »
- Schiffman JD, Chun N, Fisher PG, Dahl GV, Ford JM, Eggerding FA "Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family." Pediatr Blood Cancer 2007; More »
- Beaunoyer M, Vanatta JM, Ogihara M, Strichartz D, Dahl G, Berquist WE, Castillo RO, Cox KL, Esquivel CO "Outcomes of transplantation in children with primary hepatic malignancy." Pediatr Transplant 2007; 11: 6: 655-660 More »
20 publications: view full list
